Rye

Researchers are conducting a patient survey to better understand how CAR-T Cell therapy affects fertility in individuals diagnosed with cancer. This survey aims to gather valuable information that can help shape future treatment plans and fertility preservation methods for patients who have undergone or are currently receiving CAR-T Cell therapy. The study involves collecting data from cancer patients aged 18 years and older who have a history of receiving CAR-T Cell treatment. Participants will provide information through the survey, which focuses on their experiences related to fertility following the therapy. Participants' involvement includes completing the survey, which will gather data over a period of one year to assess the impact of CAR-T Cell therapy on fertility. The insights gained from this research will contribute to understanding fertility outcomes and guide improvements in care for future patients.